Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMP.L Regulatory News (AMP)

  • There is currently no data for AMP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Additional Investments

3 Jan 2006 07:01

Amphion Innovations PLC03 January 2006 Amphion Innovations PLC Additional Investment in Portfolio Companies 3 January 2006 - Amphion Innovations PLC ("Amphion"), the developer oftechnology and life sciences businesses, today announces that it has completedadditional investments in its existing portfolio companies amounting to $2.23million. An additional $500,000 has been invested in Motif Biosciences Inc. ("Motif") aspart of an ongoing Series B financing. Motif is a population genetics companyworking to identify the genetic causes of major diseases by working with aunique, rich, and defensible source of human genetic data from the Persian Gulfstates. An additional $750,000 has been invested in AXCESS International, Inc. ("Axcess") (AXSI.OB) as part of an ongoing financing. Axcess provides radiofrequency identification (RFID) systems for physical security and supply chainefficiencies. An additional $980,000 has been invested in FireStar Software, Inc. ("FireStar")as part of an ongoing Series E financing. FireStar is a software company thathelps institutions achieve efficiency in their business transactions with theirclients. FireStar's flagship product EdgeNode is a complete interface solutionfor automating business transactions between companies. It is designed tosupport the unique needs of multi-enterprise process integration. These follow-on investments, made in line with Amphion's strategy as outlinedprior to its August 2005 admission to AIM, follow significant milestonesachieved by each of its portfolio companies: • Motif has signed a Letter of Intent with the leading private hospital network in the United Arab Emirates (UAE); filed a provisional patent covering its research; hired a leading population geneticist and additional scientific staff, and completed three years of research and development work in the US and Gulf prior to beginning its sampling program in 2006. • Axcess announced its 4Q2005 revenue (calendar) would be significantly higher than 3Q2005, based upon the rapid increase in awareness of RFID following a WalMart supplier mandate. Axcess announced its turn-key Asset ActivatorTM RFID system for automatically locating, counting, and protecting enterprise assets such as IT equipment, test equipment, etc. Axcess' "semi-active" tag activation methodology was widely publicized in the trade press as the next wave RFID solution for enterprise tagging of personnel, assets and vehicles of all kinds, further supported by a fourth patent award. Axcess has also discussed in general terms a revolutionary new RFID product it plans to announce in detail and begin selling in 2006. • FireStar has announced the release of EdgeNode, a software product designed to simplify the integration of back-office transactions between multiple enterprises. FireStar also booked its first customer for EdgeNode and filed a broad patent for the technology, with detail examples of 17 different applications. FireStar continues to make good progress in its other market development and distribution efforts. Additionally, Raymond Mackenzie, formerly of Lazard Freres and Morgan Stanley, has been named to the Board of Directors. Richard C. E. Morgan, CEO of Amphion, said: "Since Amphion's IPO in the summerof 2005, each of these portfolio companies has made strong progress. As such,we are confident in the outlook for each business and are therefore increasingour investment in all three companies." For More Information: Financial Dynamics +44 (0) 20 7831 3113Ben Atwell / John Gilbert Amphion InnovationsBen Austin 1 (917) 686-3979baustin@amphionplc.com About Amphion Amphion Innovations plc recently listed on the AIM Exchange in London under thesymbol AMP. Amphion's business is the formation, financing, management anddevelopment of life science and technology companies, working in partnershipwith corporations, governments, universities, and entrepreneurs seeking tocommercialize their intellectual property. On the Web: www.amphionplc.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
31st Dec 20191:15 pmRNSAmphion Innovations
31st Dec 201912:36 pmRNSCancellation of trading on AIM
20th Nov 20197:00 amRNSDirectors' Dealings and Business Update
18th Oct 20197:00 amRNSSettlement of loan facility
11th Oct 20197:01 amRNSPolarean notes statement from Amphion Innovations
11th Oct 20197:00 amRNSSale of Partner Company Shares
3rd Oct 20197:00 amRNSSale of Partner Company Shares
25th Sep 20197:00 amRNSAmended Terms on Loan Facility
10th Sep 20194:56 pmRNSSale of Partner Company Shares
9th Aug 20194:14 pmRNSStatement on Amphion Innovations
9th Aug 20194:14 pmRNSDirectorate Change
9th Aug 20193:51 pmRNSSale of Partner Company Shares
1st Jul 20197:30 amRNSSuspension - Amphion Innovations Plc
27th Jun 20193:00 pmRNSAnnual Report and Accounts Update
14th Jun 20199:04 amRNSHolding(s) in Company
12th Jun 20197:00 amRNSLoan facility update
31st May 201910:28 amRNSHolding(s) in Company
20th May 20196:14 pmRNSHolding(s) in Company
1st Apr 20194:40 pmRNSSecond Price Monitoring Extn
1st Apr 20194:35 pmRNSPrice Monitoring Extension
1st Apr 20197:00 amRNSUpdate on Loan Facility
20th Mar 20197:00 amRNSHolding(s) in Company
19th Mar 20192:33 pmRNSSale of Partner Company Shares
18th Mar 20192:00 pmRNSPrice Monitoring Extension
15th Mar 20197:01 amRNSHolding(s) in Company
15th Mar 20197:00 amRNSSale of Partner Company Shares
11th Mar 20194:41 pmRNSAmended Terms on Loan Facility
26th Feb 20197:00 amRNSConvertible Promissory Note Extended
14th Feb 20198:00 amRNSStatement re. Motif Bio plc
7th Feb 20199:40 amRNSStmnt re Share Price Movement
1st Feb 20197:00 amRNSAppointment of Joint Broker
21st Jan 20197:00 amRNSWellGen Finalises License Agreement
11th Dec 20187:05 amRNSInvestment in Polarean & Loan Facility Repayment
16th Oct 20187:00 amRNSExtended Repayment and Draw Down on Loan Facility
28th Sep 20187:00 amRNSHalf-year Report
5th Sep 20187:00 amRNSBoard Change
23rd Aug 20183:20 pmRNSPolarean update
21st Aug 20187:15 amRNSMotif Bio notes statement from Amphion Innovations
21st Aug 20187:00 amRNSSale of Partner Company Shares
1st Aug 20184:47 pmRNSResult of AGM
29th Jun 20187:00 amRNSDirectorate Change
26th Jun 20187:00 amRNSFinal Results
23rd May 20187:00 amRNSMotif Bio notes statement from Amphion Innovations
23rd May 20187:00 amRNSSale of Partner Company Shares
20th Apr 20187:00 amRNSDirectorate Change
29th Mar 20187:00 amRNSAIM Admission & First Day of Dealings
29th Mar 20187:00 amRNSUpdate on Polarean Imaging IPO
26th Mar 20187:31 amRNSUpdate on Polarean Imaging proposed AIM IPO
2nd Mar 20187:00 amRNSConvertible promissory note extended to December
10th Jan 20185:09 pmRNSDirector dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.